Long-term follow-up of the German post-market study for upper airway stimulation for obstructive sleep apnea

Upper airway stimulation (UAS) is an effective treatment for obstructive sleep apnea (OSA) in positive airway pressure (PAP) failure. Most reports have presented short-term data, so long-term safety and efficacy reports are rare. The German post-market study (G-PMS) has followed approximately 60 pat...

Full description

Saved in:
Bibliographic Details
Main Authors: Steffen, Armin (Author) , Sommer, Ulrich J. (Author) , Maurer, Joachim T. (Author) , Abrams, Nils (Author) , Hofauer, Benedikt (Author) , Heiser, Clemens (Author)
Format: Article (Journal)
Language:English
Published: 2020
In: Sleep and breathing
Year: 2020, Volume: 24, Issue: 3, Pages: 979-984
ISSN:1522-1709
DOI:10.1007/s11325-019-01933-0
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s11325-019-01933-0
Verlag, lizenzpflichtig, Volltext: https://link.springer.com/article/10.1007/s11325-019-01933-0
Get full text
Author Notes:Armin Steffen, Ulrich J. Sommer, Joachim T. Maurer, Nils Abrams, Benedikt Hofauer, Clemens Heiser
Description
Summary:Upper airway stimulation (UAS) is an effective treatment for obstructive sleep apnea (OSA) in positive airway pressure (PAP) failure. Most reports have presented short-term data, so long-term safety and efficacy reports are rare. The German post-market study (G-PMS) has followed approximately 60 patients from three implanting centers for several years.
Item Description:Online publiziert: 4. September 2019
Gesehen am 19.01.2026
Physical Description:Online Resource
ISSN:1522-1709
DOI:10.1007/s11325-019-01933-0